26 Jul 2010 13:00
Immunodiagnostic Systems Holdings PLC ("the Company")
Exercise of Share Options and Total Voting Rights
Immunodiagnostic Systems Holdings PLC, a leading producer of diagnostic testing kits, announces that on 22 July 2010, 33,361 ordinary shares of 2p each in the Company ("Ordinary Shares") were allotted to satisfy an exercise of options.
Additionally, on the same day 79,422 Ordinary Shares were allotted to satisfy options exercised under a SAYE scheme. In aggregate 112,783 Ordinary Shares have been allotted and application will be made at the earliest practicable opportunity for admission of the new ordinary shares to trading on AIM.
Total Voting Rights
In accordance with FSA's Disclosure and Transparency Rules, the Company advises that its increased issued share capital comprises 27,970,023 Ordinary Shares. The voting rights of all of these shares are identical with each share carrying the right to one vote. The Company holds no ordinary shares in Treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Immunodiagnostic Systems Holdings PLC under the Disclosure and Transparency Rules.
Contacts:
| Immunodiagnostic Systems Holdings PLC | Tel: 0191 519 0660 |
| Roger Duggan, CEO |
|
| Paul Hailes, Finance Director |
|
|
|
|
| Brewin Dolphin | Tel: 0845 213 4730 |
| Andrew Emmott |
|
| Sean Wyndham-Quin |
|
|
|
|
| Walbrook PR Ltd | Tel: 020 7933 8780 |
| Helen Westaway | Mob: 07841 917 679 |
|
|
|